Mattew Evison: Single station vs multi station N2 as a defining factor for resectability of lung cancer

Matthew Evison, Professor of Thoracic Surgery, Pleural and tobacco dependency at Manchester University NHS Foundation Trust, shared on X:

“We have argued against using single station vs multi station N2 as a defining factor for resectability of lung cancer for many years and this study provides supporting evidence for this. Huge collaborative effort.

What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study

Autors: Christopher Craig, Janet Johnston, Patrick Goodley, Paul Bishop, Haider Al-Najjar, Louise Brown, Joanna Gallagher, Ramachandran Sundar, Sara Upperton, Matthew Callister, David Meek, Laura Succony, Parvez, Muhammad Tufail, Geeshath Jayasekera, John Maclay, Alana Livesey, Ian Woolhouse, Natalie Smith, Anna Bibby, Matthew Evison,

With thanks to Christopher Craig for leading and all collaborators Mat Callister, Ian Woolhouse, Patrick Goodley, Bristol Academic Respiratory Unit, Louise Brown and many others”

Source: Mattew Evison/X